Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Follows people with COPD in China to study disease outcomes

Builds a large cohort of adults with COPD to study outcomes and biomarkers.

Plain-language title generated from the registry record
Registry title: The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 75 years old?

Source: NCT03044847, who can take part

Where in China

  • Capital Medical UniversityBeijing, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beijing Chao Yang Hospital
Trial code
NCT03044847
Record updated
29 July 2021
Original description
The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices and to monitor and improve clinical outcomes in this disease.Read full original descriptionShow less

The Cohort Study for Chronic Obstructive Pulmonary Diseases (COPD) in China---- Observation of the Disease Outcome and Identification of Prognostic Biomarkers for the Disease Outcome

The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices and to monitor and improve clinical outcomes in this disease.

Inclusion: Aged 40-75 years; COPD group: baseline post-bronchodilator FEV1/FVC < 0.7; GOLD 0 group: individuals with chronic respiratory symptoms and/or high risk factors; Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.

Exclusion: thoracic or abdominal surgery in the last 3 months; eye surgery in the last three months; Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc; The usual criteria of serious uncontrolled diseases; myocardial infarction in the last 3 months; admission to hospital for any cardiac condition in the last month; heart rate over 120 beats per minute; antibacterial chemotherapy for tuberculosis; Acute exacerbation in the past 3 months; retinal detachment; pregnant or breast feeding.

ClinicalTrials.gov NCT03044847